For the year ended 31 March 2016
Unaudited Abbreviated Report and Financial Statements
England and Wales
Registered Number: 02278935
Nash Pharmacy Limited
For the year ended 31 March 2016
1
Accountant's Report
2
Balance Sheet
3 to 5
Notes to the Abbreviated Financial Statements
Nash Pharmacy Limited
Accountant's Report
For the year ended 31 March 2016
Accountants
'
report on the financial statements to the directors of Nash Pharmacy Limited
.
|
In accordance with our terms of engagement and in order to assit you to fulfill your duties under the Companies Act
|
2006
,
we have compiled the financial statements of the company for the period ending year ended
31
March
2016
|
which comprise of the Profit and Loss Account
,
the Balance Sheet and the related notes from the accounting
|
records and information and explanations you have given to us
.
|
This report is made to the company
'
s Board of Directors
,
as a body
,
in accordance with the terms of our
|
engagement
.
Our work has been undertaken so that we might compile the financial statements that we have been
|
engaged to compile
,
report to the company
'
s Board of Directors that we have done so and state those matters that
|
we have agreed to state to them in this report and for no other purpose
.
To the fullest extent permitted by law
,
we
|
do not accept or asume responsibility to anyone other than the company and the company
'
s Board of Directors
,
as
|
a body
,
for our work or for this report
.
|
You have acknowledged on the Balance Sheet as at year ended
31
March
2016
your duty to ensure that the
|
company has kept the correct accounting records to prepare financial statements that give a true and fair view
|
under the Companies Act
2006
.
You consider that the company is expemt from statutory requirement for an audit
|
for the period
.
|
We have not been instructed to carry out an audit of the financial statements
.
For this reason
,
we have not verified
|
the accuracy or completeness of the accounting records or information and explanations you have given to us and
|
we do not
,
therefore
,
express any opinion on the financial statements
.
|
Stonebridge Accountants
19a Chorley Old Road
Bolton
Lancashire
BL1 3AD
02 November 2016
1 of 5
Notes to the Abbreviated Financial Statements
|
Nash Pharmacy Limited
For the year ended 31 March 2016
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).
|
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
|
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Acquired goodwill is stated at cost less amortisation
.
Amortisation is calculated on a straight line basis over the
|
estimated expected useful economic life of the goodwill of
10
years
.
|
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
|
Land and Buildings
Property Improvements
Motor Vehicles
Fixtures and Fittings
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
|
3 of 5
Notes to the Abbreviated Financial Statements
|
Nash Pharmacy Limited
For the year ended 31 March 2016
2
Intangible fixed assets
|
582,400
(90,400)
492,000
77,254
(18,014)
8,655
Charge for year
67,895
424,105
505,146
1,150,092
1,150,092
458,712
27,121
Charge for year
485,833
664,259
691,380
2015
2016
4
Creditors due after more than one year
|
10,137
128,875
Bank loans and overdrafts (secured)
125,466
262,520
135,603
391,395
4 of 5
Notes to the Abbreviated Financial Statements
|
Nash Pharmacy Limited
For the year ended 31 March 2016
Allotted called up and fully paid
|
2016
2015
100
Class A shares of £
1
.
00
each
|
100
100
100
100
5 of 5